ANTH
Anthera Pharmaceuticals, Inc.
ANTH
ANTH
Delisted
ANTH was delisted on the 27th of June, 2018.
35 hedge funds and large institutions have $20.5M invested in Anthera Pharmaceuticals, Inc. in 2014 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 13 increasing their positions, 8 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
89% less call options, than puts
Call options by funds: $13K | Put options by funds: $121K
Holders
35
Holding in Top 10
–
Calls
$13K
Puts
$121K
Top Buyers
| 1 | +$1.6M | |
| 2 | +$1.03M | |
| 3 | +$237K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$192K |
| 5 |
RPAM
Rhenman & Partners Asset Management
Stockholm,
Sweden
|
+$192K |
Top Sellers
| 1 | -$3.16M | |
| 2 | -$1.52M | |
| 3 | -$678K | |
| 4 |
Renaissance Technologies
New York
|
-$188K |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$132K |